Related Experiment Video
Updated: Sep 11, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Calcific Aortic Valve Stenosis: A Focal Disease in Older and Complex Patients-What Could Be the Best Time for an
Annamaria Mazzone1, Augusto Esposito1, Ilenia Foffa1,2
1Fondazione Toscana Gabriele Monasterio Massa, 54100 Massa, Italy.
Insights
Calcific aortic stenosis (CAS) management in the elderly is complex. This review integrates aging factors and biomarkers to determine optimal timing for interventions like aortic valve replacement (AVR).
Area of Science:
- Cardiology
- Geriatrics
- Biomarker Research
Background:
- Calcific aortic stenosis (CAS) is a growing concern in aging populations worldwide.
- Decisions regarding aortic valve replacement (SAVR, TAVR) for severe CAS in elderly patients are complex, balancing risks and benefits.
- CAS in older adults involves multifaceted factors beyond valve disease, including aging, frailty, and comorbidities.
Purpose of the Study:
- To analyze the natural history and progression of aortic stenosis in the elderly.
- To explore phenotypes of myocardial damage and heart failure in aging patients with CAS.
- To propose optimal timing for interventional treatment of CAS in older individuals using integrated biomarkers.
Main Methods:
- Review of natural and prognostic histories of aortic stenosis progression.
- Analysis of myocardial damage and heart failure phenotypes in aging.
- Integration of clinical, geriatric, chemical, and advanced imaging biomarkers.
Main Results:
- CAS in the elderly presents significant phenotypic heterogeneity and complex aging trajectories.
- Subjective symptoms alone are insufficient for determining optimal intervention timing.
- A comprehensive biomarker approach is crucial for personalized treatment decisions.
Conclusions:
- Optimal interventional timing for CAS in elderly patients requires integrating multiple data sources.
- Biomarker-driven strategies can improve outcomes beyond symptom-based assessments.
- Personalized management is key to avoiding adverse events and improving quality of life in older adults with CAS.
Abstract:
Calcific aortic stenosis (CAS) is a newly emerging pandemic in elderly individuals due to the aging of the population in the world. Surgical Aortic Valve Replacement (SAVR) and Transcatheter Aortic Valve Replacement (TAVR) are the cornerstone of the management of severe aortic stenosis accompanied by one or more symptoms. Moreover, an appropriate interventional treatment of CAS, in elderly patients, is a very complex decision for heart teams, to avoid bad outcomes such as operative mortality, cardiovascular and all-cause death, hospitalization for heart failure, worsening of quality of life. In fact, CAS in the elderly is not only a focal valve disease, but a very complex clinical picture with different risk factors and etiologies, differing underlying pathophysiology, large phenotypic heterogeneity in a context of subjective biological, phenotypic and functional aging until frailty and disability. In this review, we analyzed separately and in a more integrated manner, the natural and prognostic histories of the progression of aortic stenosis, the phenotypes of myocardial damage and heart failure, within the metrics and aging trajectory. The aim is to suggest, during the clinical timing of valve disease, the best interval time for an appropriate and effective interventional treatment in each older patient, beyond subjective symptoms by integration of clinical, geriatric, chemical, and advanced imaging biomarkers.
More Related Videos
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Aneurysm III: Interprofessional Care
Mitral Regurgitation III: Medical Management
Aortic Regurgitation IV: Nursing Management
Aortic Regurgitation I: Introduction